Ruthenium and Other Non-Platinum Anticancer Compounds
作者： Ioannis Bratsos , Teresa Gianferrara , Enzo Alessio , Christian G Hartinger , Michael A Jakupec
DOI: 10.1002/9783527633104.CH5
关键词:
摘要:
sci-hub.se 参考文章(95)
Maria-Grazia Mendoza-Ferri, Christian G. Hartinger, Rene E. Eichinger, Natalya Stolyarova, Kay Severin, Michael A. Jakupec, Alexey A. Nazarov, Bernhard K. Keppler, Influence of the Spacer Length on the in Vitro Anticancer Activity of Dinuclear Ruthenium−Arene Compounds Organometallics. ,vol. 27, pp. 2405- 2407 ,(2008) , 10.1021/OM800207T
M. A. Jakupec, P. Unfried, B. K. Keppler, Pharmacological properties of cerium compunds Reviews of Physiology Biochemistry and Pharmacology. ,vol. 153, pp. 101- 111 ,(2005) , 10.1007/S10254-004-0024-6
Toshinori Sato, Mineo Hashizume, Yasunobu Hotta, Yoshio Okahata, Morphology and proliferation of B16 melanoma cells in the presence of lanthanoid and Al3+ ions. Biometals. ,vol. 11, pp. 107- 112 ,(1998) , 10.1023/A:1009273827598
Katherine D. Weaver, Jared J. Heymann, Arnav Mehta, Petra L. Roulhac, Damon S. Anderson, Andrew J. Nowalk, Pratima Adhikari, Timothy A. Mietzner, Michael C. Fitzgerald, Alvin L. Crumbliss, Ga3+ as a mechanistic probe in Fe3+ transport: characterization of Ga3+ interaction with FbpA Journal of Biological Inorganic Chemistry. ,vol. 13, pp. 887- 898 ,(2008) , 10.1007/S00775-008-0376-5
J. Lu, E.-H. Chew, A. Holmgren, Targeting thioredoxin reductase is a basis for cancer therapy by arsenic trioxide Proceedings of the National Academy of Sciences of the United States of America. ,vol. 104, pp. 12288- 12293 ,(2007) , 10.1073/PNAS.0701549104
Fumihiko Hayakawa, Martin L Privalsky, Phosphorylation of PML by mitogen-activated protein kinases plays a key role in arsenic trioxide-mediated apoptosis Cancer Cell. ,vol. 5, pp. 389- 401 ,(2004) , 10.1016/S1535-6108(04)00082-0
Mathieu Auzias, Bruno Therrien, Georg Süss-Fink, Petr Štěpnička, Wee Han Ang, Paul J. Dyson, Ferrocenoyl pyridine arene ruthenium complexes with anticancer properties: synthesis, structure, electrochemistry, and cytotoxicity. Inorganic Chemistry. ,vol. 47, pp. 578- 583 ,(2008) , 10.1021/IC7018742
Aviva Levina, Anannya Mitra, Peter A. Lay, Recent developments in ruthenium anticancer drugs. Metallomics. ,vol. 1, pp. 458- 470 ,(2009) , 10.1039/B904071D
Wee Han Ang, Lorien J Parker, Anastasia De Luca, Lucienne Juillerat‐Jeanneret, Craig J Morton, Mario Lo Bello, Michael W Parker, Paul J Dyson, Rational Design of an Organometallic Glutathione Transferase Inhibitor Angewandte Chemie. ,vol. 48, pp. 3854- 3857 ,(2009) , 10.1002/ANIE.200900185
P. Heffeter, M.A. Jakupec, W. Körner, P. Chiba, C. Pirker, R. Dornetshuber, L. Elbling, H. Sutterlüty, M. Micksche, B.K. Keppler, W. Berger, Multidrug-resistant cancer cells are preferential targets of the new antineoplastic lanthanum compound KP772 (FFC24). Biochemical Pharmacology. ,vol. 73, pp. 1873- 1886 ,(2007) , 10.1016/J.BCP.2007.03.002